Edward H Myles - Net Worth and Insider Trading
Edward H Myles Net Worth
The estimated net worth of Edward H Myles is at least $187,368 dollars as of 2023-03-30. Edward H Myles is the CFO of Scholar Rock Holding Corp and owns about 24,150 shares of Scholar Rock Holding Corp (SRRK) stock worth over $187,283. Edward H Myles is also the VP of Finance & CFO of Pressure BioSciences Inc and owns about 67 shares of Pressure BioSciences Inc (PBIO) stock worth over $85. Details can be seen in Edward H Myles's Latest Holdings Summary section.
Transaction Summary of Edward H Myles
Edward H Myles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward H Myles owns 4 companies in total, including Scholar Rock Holding Corp (SRRK) , AMAG Pharmaceuticals Inc (AMAG) , and Ocata Therapeutics Inc (OCAT) among others .
Click here to see the complete history of Edward H Myles’s form 4 insider trades.
Insider Ownership Summary of Edward H Myles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 2018-11-19 | director |
| AMAG | AMAG Pharmaceuticals Inc | 2020-03-10 | COO & CFO |
| OCAT | Ocata Therapeutics Inc | 2016-02-10 | COO & CFO |
| PBIO | Pressure BioSciences Inc | 2006-04-03 | Vice President of Finance/CFO |
Edward H Myles Latest Holdings Summary
Edward H Myles currently owns a total of 2 stocks. Among these stocks, Edward H Myles owns 24,150 shares of Scholar Rock Holding Corp (SRRK) as of November 15, 2021, with a value of $187,283 and a weighting of 99.95%. Edward H Myles also owns 67 shares of Pressure BioSciences Inc (PBIO) as of September 7, 2006, with a value of $85 and a weighting of 0.05%.
Latest Holdings of Edward H Myles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 2021-11-15 | 24,150 | 7.76 | 187,283 |
| PBIO | Pressure BioSciences Inc | 2006-09-07 | 67 | 1.27 | 85 |
Holding Weightings of Edward H Myles
Edward H Myles Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward H Myles has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Scholar Rock Holding Corp is the sale of 78,301 shares on November 15, 2021, which brought Edward H Myles around $3 Million.
According to the SEC Form 4 filings, Edward H Myles has made a total of 0 transactions in Pressure BioSciences Inc (PBIO) over the past 5 years. The most-recent trade in Pressure BioSciences Inc is the acquisition of 33 shares on September 7, 2006, which cost Edward H Myles around $3,000.
Insider Trading History of Edward H Myles
- 1
Edward H Myles Trading Performance
GuruFocus tracks the stock performance after each of Edward H Myles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward H Myles is 20.09%. GuruFocus also compares Edward H Myles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward H Myles within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Edward H Myles's insider trading performs compared to the benchmark.
Performance of Edward H Myles
Average Relative Return
30.1%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 22.08 | 20.09 | 32.24 | 30.1 | -3.17 | -21.49 |
| Relative Return to S&P 500(%) | 18.51 | 12.45 | 24.42 | 18.92 | -2.14 | -13.85 |
Edward H Myles Ownership Network
Ownership Network List of Edward H Myles
Ownership Network Relation of Edward H Myles
Edward H Myles Owned Company Details
What does Scholar Rock Holding Corp do?
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.
Who are the key executives at Scholar Rock Holding Corp?
Edward H Myles is the director of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include Chief Medical Officer Jing L. Marantz , CEO-Elect Jay T. Backstrom , and 10 percent owner Amaury Wittouck .
Scholar Rock Holding Corp (SRRK) Insider Trades Summary
Over the past 18 months, Edward H Myles made 1 insider transaction in Scholar Rock Holding Corp (SRRK) with a net sale of 78,301. Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net purchase of 277,916 shares made by Invus Public Equities, L.p. , a net purchase of 1,197,992 shares made by Amir Nashat ,
In summary, during the past 3 months, insiders sold 1,094 shares of Scholar Rock Holding Corp (SRRK) in total and bought 48,774 shares, with a net purchase of 47,680 shares. During the past 18 months, 79,395 shares of Scholar Rock Holding Corp (SRRK) were sold and 1,477,002 shares were bought by its insiders, resulting in a net purchase of 1,397,607 shares.
Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Scholar Rock Holding Corp Insider Transactions
Edward H Myles Mailing Address
Above is the net worth, insider trading, and ownership report for Edward H Myles. You might contact Edward H Myles via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.
